PRESS RELEASE NANAIMO, British Columbia – Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that it has closed its offering of 5.00% Convertible Senior Notes due 2023 (the “notes”) for gross proceeds of US$450 million in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities […]
Tilray
Tilray® Strengthens Presence in Latin America with Acquisition of Alef Biotechnology
PRESS RELEASE NANAIMO, British Columbia and SANTIAGO, Chile – Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research and production, today announced that it has completed an acquisition of its existing import and distribution partner Alef Biotechnology SpA (“Alef”). The acquisition will allow Tilray to import, produce and distribute Tilray branded medical cannabis products […]
Cannabis stock Tilray plunges 16% after PepsiCo CFO says company has no plans for marijuana
Cannabis stocks fell across the board Tuesday after PepsiCo told investors that the food and beverage giant said it has no plans to invest in marijuana. Though most of the marijuana stocks opened Tuesday without much fanfare, they took a leg lower after PepsiCo Chief Financial Officer Hugh Johnston told Cowen analyst Vivien Azer on the company’s […]
Tilray® Receives Approval from U.S. Government to Import a Medical Cannabis Study Drug for a Clinical Trial at the University of California San Diego Center for Medicinal Cannabis Research
PRESS RELEASE U.S. Drug Enforcement Administration approves import of a pharmaceutical-grade medical cannabis product produced by Tilray into the United States for a clinical trial focused on Essential Tremor NANAIMO, B.C. – Tilray Inc. (NASDAQ:TLRY) today announced that the U.S. Drug Enforcement Administration (DEA) has granted approval to import a cannabinoid study drug into the […]
The Statistic in Tilray’s Prospectus That Should Have Marijuana Stock Investors Salivating
Chances are you probably overlooked this big-picture figure prior to Tilray’s initial public offering. In case you haven’t noticed, marijuana stocks are blazing hot once again. This budding industry has taken flight on the expectation of rapidly rising sales and big profits tied to Canada’s legalization of recreational marijuana in 36 days’ time. When it […]
Tilray, Inc. Reports Second Quarter 2018 Earnings
PRESS RELEASE NANAIMO, BRITISH COLUMBIA – Tilray, Inc., (“Tilray” or the “Company”) (NASDAQ: TLRY) a global pioneer in cannabis production and distribution, today reported financial results for second quarter and six months ended June 30, 2018. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “We are very pleased with […]
Tilray® Selected by Nova Scotia Liquor Corporation to Supply a Variety of Adult-Use Cannabis Brands and Products
PRESS RELEASE Brands Marley Natural and CANACA to become available in Nova Scotia through the Nova Scotia Liquor Corporation starting Oct. 17, 2018 TORONTO, ONT. – Tilray Canada Ltd. (“Tilray”), a wholly owned subsidiary of Tilray, Inc. (Nasdaq: TLRY) announced today that it has been selected by the Nova Scotia Liquor Corporation (“NSLC”) to receive […]
OOOO…(what a week it was) CANADA, “our home and native land. True patriot love in all of us command”
What started out as just another one of those long conference weeks morphed into the “Brave New World of Cannabis” with the Tuesday morning announcement of Constellation Brands $5 Billion Canadian dollar (yes with a B not an M) investment in Canopy Growth. Some would argue it was the most significant financial news ever for […]
SEC vs. Tilray: What regulators wanted to know about the largest U.S. pot IPO
Tilray removed entire CEO letter from IPO filing, according to SEC documents As the largest pot IPO in the U.S. was on deck earlier this year, the Securities and Exchange Commission sought to cut down on Tilray Inc.’s soaring rhetoric and add disclosures about the side effects of weed, according to SEC documents made public […]
Canadian Marijuana Firm Tilray Valued At $1.4 Billion Ahead Of Its Thursday IPO
Tilray Inc., Canadian marijuana producer and processor, will IPO on Thursday, June 19. At a price range of $14 to $16 per share, the company plans to raise up to $144 million and has an expected market cap of ~$1.4 billion. At the midpoint of its price range, TLRY currently earns an unattractive rating. Tilray looks […]
